Dubai: Bahrain has begun phase three of clinical trials for a COVID-19 vaccine, Bahrain News Agency (BNA) reported.
The clinical trials are being conducted in cooperation with those in charge of the experience from the UAE and their Chinese partners, Supreme Council of Health (SCH) President and National Medical Task Force to Combat the Coronavirus (COVID-19) Chairman, Lieutenant-General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, has revealed.
SEE ALSO
- COVID-19: UAE residence visa expiry rule amended. Here's the latest updated information
- COVID-19 Birth in UAE: All you need to know about pregnancy and birth during the pandemic
- COVID-19: I have a UAE entry permit, do I need a GDRFA approval?
- COVID -19: Spike in infections prompt lockdown in certain key spots in India and South East Asia
SCH chief was speaking as he received yesterday a delegation of the officials of the potential vaccine, including those in charge of the experience in the UAE, Dr. Nawal Al Kaabi and Dr. Waleed Abbas, in addition to representatives of Sinopharm’s China National Biotec Group (CNBG), and artificial intelligence and cloud computing company, Group 42.
Dr. Shaikh Mohammed bin Abdulla revealed that the kingdom will participate in the first global clinical trials for the third phase of WHO-listed potential coronavirus vaccine, noting that the vaccine will be tested on 6,000 volunteer citizens and residents in Bahrain.
SCH President highlighted the efforts made by the kingdom and the National Medical Task Force to Combat the Coronavirus to fight the pandemic and ensure the health and safety of the citizens and residents.
